Lisdexamfetamine, marketed as Vyvanse, is a medicated drug approved in Canada for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children and people. It's functions as a prodrug, meaning it’s unchanged until broken down by the body, providing dextroamphetamine gradually over an extended